Your browser doesn't support javascript.
loading
Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults.
Mattila, Tiina; Vasankari, Tuula; Kanervisto, Merja; Laitinen, Tarja; Impivaara, Olli; Rissanen, Harri; Knekt, Paul; Jousilahti, Pekka; Saarelainen, Seppo; Puukka, Pauli; Heliövaara, Markku.
Afiliación
  • Mattila T; Department of Lung Diseases, Helsinki University Hospital, Meilahti Triangle Hospital, 6th Floor, PO Box 372, 00029 HUS, Finland. Electronic address: tiina.m.mattila@fimnet.fi.
  • Vasankari T; Finnish Lung Health Association (FILHA), Filha ry, Sibeliuksenkatu 11 A 1, 00250 Helsinki, Finland. Electronic address: tuula.vasankari@filha.fi.
  • Kanervisto M; School of Health Sciences, University of Tampere, Niittytie 1, 33470 Ylöjärvi, Finland. Electronic address: Merja.Kanervisto@uta.fi.
  • Laitinen T; Division of Medicine, Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital and University of Turku, PO Box 52 (Hämeentie 11), 20521 Turku, Finland. Electronic address: tarja.helena.laitinen@tyks.fi.
  • Impivaara O; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: olli.impivaara@thl.fi.
  • Rissanen H; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: harri.rissanen@thl.fi.
  • Knekt P; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: paul.knekt@thl.fi.
  • Jousilahti P; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: pekka.jousilahti@thl.fi.
  • Saarelainen S; Department of Respiratory Medicine, Tampere University Hospital, 33521 Tampere, Finland. Electronic address: seppo.saarelainen@pshp.fi.
  • Puukka P; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: pauli.puukka@thl.fi.
  • Heliövaara M; National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland. Electronic address: markku.heliovaara@thl.fi.
Respir Med ; 109(8): 1012-8, 2015 Aug.
Article en En | MEDLINE | ID: mdl-26108990
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vigilancia de la Población / Medición de Riesgo / Enfermedad Pulmonar Obstructiva Crónica / Predicción Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Respir Med Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vigilancia de la Población / Medición de Riesgo / Enfermedad Pulmonar Obstructiva Crónica / Predicción Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Respir Med Año: 2015 Tipo del documento: Article